SCHEDULE: Coghill Capital Discloses 8.6% Stake in Health Catalyst

Clint D. Coghill and associated entities have filed an amended Schedule 13G reporting an 8.6% beneficial ownership stake in Health Catalyst, Inc.

Summary

• Reporting persons including Stoney Lonesome HF LP, Coghill Capital Management LLC, and Clint D. Coghill have updated their beneficial ownership of Health Catalyst, Inc. common stock.
• The group collectively reports beneficial ownership of 6,308,345 shares.
• This represents approximately 8.6% of the total 73,586,183 shares outstanding as of March 5, 2026.
• The filing confirms the holdings are held for investment purposes and not to influence control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory filing reflecting existing investment positions rather than a change in company strategy or performance.

Positives

• Demonstrates significant long-term institutional or high-net-worth investor confidence in the company's equity.

Negatives

• None identified; this is a standard regulatory disclosure of ownership.

Risks

• Market volatility affecting the value of the investment.
• Potential for future divestment by the reporting persons which could impact share price.

Future Outlook

The reporting persons state that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors holding over 5% of a company's stock, signaling stable, passive investment interest in the healthcare technology sector.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for passive investors under Rule 13d-1.
• Ownership levels are consistent with typical institutional block-holding patterns in mid-cap healthcare technology firms.

Stakeholder Impact

• Shareholders may view the 8.6% stake as a sign of institutional support for the company's long-term prospects.

Next Steps

• Continued monitoring of future 13G/13D filings for changes in position size.

Key Dates

Keywords

Health Catalyst, Schedule 13G, Beneficial Ownership, Clint D. Coghill, Institutional Investor, Equity Disclosure